Search Report
Home   About Us   Press Room   Custom Research   Research Store   Contact Us
Press Releases

 

Increasing Incidences of Diseases Boosting the Global IVD Market

May 24, 2011
Share |
 
According to our new research report Global In Vitro Diagnostic Market Analysis, the global IVD sector is witnessing significant developments across many countries around the globe. Despite the global recession, the industry continued to show its stupendous performance and reached to the mark of US$ 44 Billion in 2010. Factors, such as increasing prevalence of diseases, strong demand for testing equipments in emerging countries, and private sector participation are some of the prominent factors driving growth. It is estimated that, the global IVD market will grow at a CAGR of around 5% during 2011-2013.
 
We have found that, the presence of several life threatening diseases has boosted the demand for effective and modern diagnostic equipments. The market for diabetes diagnostic & therapies reached to the mark of US$ 38 Billion in 2010. For diabetes, cancer, HIV, tuberculosis and others, the market players are launching diagnostic products with cutting edge technologies. High penetration of these diseases, therefore, presents an optimistic future for diagnostics industry.
 
The report Global In Vitro Diagnostic Market Analysis presents a broad overview of the key market drivers, and their significance in the enlargement of industry revenue patterns. Moreover, the report analyzes the overall industry performance with respect to key segments, such as point-of-care diagnostics, molecular diagnostics, hematology etc. It provides a significant coverage of region-wise scenario in the IVD market. An in-depth analysis of the market across various diseases has also been shown.
 
The report is an outcome of an extensive research and prudent analysis of the global IVD market, emphasizing data reliability, and content presentation. It covers all the necessary aspects of the market and presents an overview of the emerging sectors. The forecast in key areas of the report makes use of effective methods and techniques that seek to present a realistic outlook. The coverage of description and important developments of active market players completes the overall analysis structure.  

For more information visit: http://www.rncos.com/Report/IM103.htm

Related Press Releases:
» US Generic Drugs to Grow Strongly in Future
» FDI Fuelling Growth of Hospital Services in India
» Indian Diagnostic Market Poised to Grow at 16% CAGR
» Next-Generation Sequencing Market to Touch US$ 2 Billion-Mark by 2015
» European Regenerative Medicine Market worth US$ 2.2 Billion in 2010
 
Related Research Reports
Related Research News
May 03, 2010
New Product Launches Led US Pharma Market to Grow Strongly in 2009
Apr 30, 2010
India to be Among Top 10 Drug Producers by 2020
Apr 05, 2010
China ? On the Way to Become Third Largest Pharma Market
Jan 25, 2010
Indian Government to Set Up Special Zones to Boost Pharma Exports
Phone : +91 (120) 4224700/01/02/03
Fax : +91 (120) 4224707

Copyright © 2011, RNCOS, 2002-2011

Home
About Us
Careers
Request a Quote
Discounted Reports
Contact Us
Add URL
FAQ
Upcoming Reports